Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells

Yongchao Wang(Augusta University), Kapil N. Bhalla(University of South Florida)
Blood
October 15, 2009
Cited by 177


Related Papers